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Opening wedge high tibial osteotomy in combination with anterior 
cruciate ligament-reconstruction
A.B. Stibbe
Orthopedic Surgery, Meander Medisch Centrum, Amsterdam, 
Netherlands
Purpose: Articular cartilage lesions generally do not heal, or heal 
only partially under certain biological and mechanical conditions. 
Important mechanical conditions are a proper alignment of the 
LOFFBOETVG¾DJFOUTUBCJMJUZ&TQFDJBMMZIJHIJNQBDUTQPSUDBODBVTF
a lesion of the anterior cruciate ligament (ACL). Chronic instability 
can lead to osteoarthrosis and some of these patients develop varus 
malalignment with narrowing of the medial knee compartment. 
Reconstruction of the ACL in presence of malalignment compromises 
the success of the operation, and instability re-occurs. Opening 
wedge high tibial osteotomy (HTO) has been shown to reduce pain 
and improve function in varus gonarthrosis. However, an HTO does 
only partially improve the stability. Therefore, for these patients, 
we combined the HTO with an ACL reconstruction. The goal of this 
TUVEZJTUPEFTDSJCFUIFQSJNBSZSFTVMUTPGUIF¾STUQBUJFOUTXJUIB
DPNCJOFEPQFOJOHXFEHF)50XJUIUIFOFX%ZOB¾Y74PTUFPUPNZ
system and a reconstruction of the ACL with hamstring tendons 
	5SBOT¾YTZTUFN

Methods and Materials: One experienced knee surgeon performed 
10 combined HTO-ACL procedures between January 2004 en August 
2005. The HTO was placed using the medial approach with an 
incision of 5 cm and the ACL reconstruction was performed using 
UIFIBNTUSJOHTUFDIOJRVF1SPYJNBM¾YBUJPOXJUIUIF5SBOT¾YTDSFX
and distally with a bio-absorable screw (Arthrex, Naples, Florida, 
64"
5PTUBCJMJ[FUIFPTUFPUPNZXFVTFEUIF%ZOB¾Y74PTUFPUPNZ
system (Biomet Inc, Warsah, USA). Nine patients were active (age 
32 - 50 years, 3 females and 7 males) and had a history of knee pain 
due to varus-medial compartmental arthrosis and instability (1 - 30 
years) and 2 - 5 previous surgeries on the knee. 
Results: The mean operating-time was 1 hour and 50 minutes 
(1.30 - 2.15). There was one technical error (over-valgisation). The 
operations were considered as challenging, but good to perform 
in reasonable time. During follow-up (6 - 30 month) all 10 patients 
showed excellent osteotomy healing. One patient had 5 degress of 
loss of correction, but had a good result. Nine patients had good to 
excellent pain relief and improvement of function with restoration of 
the stability. The mean alignment angle improved from a mean of 2.1 
degrees of varus to a mean of 5.7 degrees of valgus. One patient had 
BOPWFSDPSSFDUJPOCVUXBTTBUJT¾FEBOEDPVMESFUVSOUPXPSL0OF
QBUJFOUIBEBTVQFS¾DJBMJOGFDUJPOBGUFSUIFJOJUJBMPQFSBUJPO	BOEBMTP
after removal of the hard-ware after one year). He was graded as a 
good result. 
Conclusions: Concomitant HTO-ACL procedures showed promising 
short term results in patients with varus gonarthrosis and ACL 
instability. The operation was demanding, but well to perform by an 
experienced knee surgeon. All patients showed excellent osteotomy 
healing, whereas one patient had some loss of correction. One 
QBUJFOUIBEBOPWFSDPSSFDUJPO0OFQBUJFOUBTVQFS¾DJBM JOGFDUJPO
Nine patients showed good/excellent results with pain relief, 
restored stability and function. Further studies are on-going to 
establish if this method also gives good long term results. 
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.PEFSONBSLFSQSPUFJOT JO TFSVNBOETZOPWJBM¿VJE JOQBUJFOUT
with different onset of knee osteoarthritis: Can we identify a “high 
SJTL³QBUJFOUQSP¾MF GPS JODJEFODFBOESBQJEQSPHSFTTJPOPGLOFF
osteoarthritis ?
C.J. Dynybil, A. Schulze, M. Sauerschnig, C. Perka;
Orthopaedic Surgery, Center for Musculoskeletal Surgery, Berlin, 
Germany
Purpose: To identify on either those patients who will experience 
rapid progression of disease or those who will not. 
Methods and Materials: 68 patients with advanced OA were 
randomized in patients with early onset of OA (<60 y), average 
onset for OA (60-70 y) and late onset of OA (>70 y). The KOOS 
was used to assess the patients` symptoms and function. Serum 
BOE TZOPWJBM ¿VJE TBNQMFTXFSF PCUBJOFE BOE BOBMZ[FE CZ &-*4"
for MMP-1, MMP-3, MMP-13, TIMP-1, TIMP-2, CPII and C2C. The 
EFHSFFPGJO¿BNNBUJPOJOUIFTZOPWJBMUJTTVFXBTBTTFTTFECZUIF
Histopathological Synovitis Score of Krenn. 




(SF) concentrations of MMP-1 and MMP-3 but showed no correlation 
with serum levels. MMP-13 was not associated with an early onset of 
0"5*.1MFWFMTJO4'XFSFTJHOJ¾DBOUMZMPXFS	Q<.05) in the early 
OA group and revealed a ratio of 1.7:1 to MMP-1 and 1:40.3 to MMP-
3. This ratio improved in the later OA groups. The CPII:C2C ratio was 
in the early and the average OA group around the half of that in the 
late OA group (p<.05). SF levels of C2C and CPII did not correlate 
with serum levels. 
Conclusions: Increased MMP-1 and -3 and decreased TIMP-2 
MFWFMTJOTZOPWJBM¿VJETIPXFEBIJHIFSSJTLPGFBSMZ0"BTXFMMBT
TZOPWJUJTHSBEFJOEJDBUJOHBQPUFOUJBMDPOUSJCVUJPOPGJO¿BNNBUPSZ
mediators to an earlier onset of OA.
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4BGFUZ FG¾DBDZ BOE BDDFQUBCJMJUZ PG ¿BWPDPYJE 	-JNCSFM

compared with naproxen in subjects with osteoarthritis of the 
knee: a pilot study
R. Levy1, R. Saikovsky2, E. Shmidt3, A. Khokhlov4;
1Clinical Development, Primus Pharmaceuticals, Inc., Scottsdale, AZ, 
United States of America, 2Rheumatology, Clinical Hospital #83 of 
Federal Agency, Moscow, Russian Federation, 3Rheumatology, City 
Clinical Hospital #1, Moscow, Russian Federation, 4Rheumatology,
Yaraslavl Clinical Trials Center based in City Hospital #2, Yaroslayl, 
Russian Federation
Purpose: The present study was designed to compare the 
effectiveness and safety of Flavocoxid, a dual pathway inhibitor anti-
JO¿BNNBUPSZBHFOUPGCPUBOJDBMPSJHJOUPOBQSPYFOJOBQPQVMBUJPO
of subjects with moderate-severe OA. 
Methods and Materials: In this double blind study 103 Russian 
subjects were randomly assigned to receive either Flavocoxid 
(500 mg BID) or naproxen (500 mg BID) for one month. Outcome 
measures included the short WOMAC scale (validated in Russian) 
subject VAS scales for discomfort and global response, investigator 
VAS for global response and fecal occult blood. 
Results: #PUIHSPVQTOPUFETJHOJ¾DBOU SFEVDUJPO JO UIF TJHOTBOE
symptoms of knee OA. There were no statistically detectable 
differences between the Flavocoxid and naproxen groups with 
respect to any of the outcome variables (p</=.001) nor with respect 
to any adverse event although there was a trend toward a higher 
incidence of edema in the naproxen group. 
Conclusions: In this short term pilot study Flavocoxid appeared to 
be as effective as naproxen in controlling the signs and symptoms 
of OA of the knee. A low incidence of adverse events was reported 
for both groups. 
